Tang, Jiyang
Sun, Yaoyao
Jin, Enzhong
Yao, Yuou
Cai, Yi
Zeng, Qiaozhu
Miao, Heng
Funding for this research was provided by:
Beijing Star Macular Disease Foundation (2025-Z-13)
Article History
Received: 14 April 2026
Accepted: 14 June 2026
First Online: 18 June 2026
Declarations
:
: The study and off-label use of Ozurdex were approved by the Ethics Committee of Peking University People’s Hospital and adhered to the tenets of the Declaration of Helsinki. Written informed consent was obtained from the participant prior to her inclusion in the study.
: Informed consent has been obtained from the participant for publication.
: The authors declare no competing interests.